Skip to main content
Clinical Trials/CTRI/2015/10/006325
CTRI/2015/10/006325
Not yet recruiting
未知

A randomized controlled study to evaluate autologous platelet rich plasma as an ideal substance for submucosal injection during endoscopic mucosal resection

Andhra Medical College0 sites90 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Andhra Medical College
Enrollment
90
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with sessile gastrointestinal polyps of diameter 1mm to 20mm diagnosed by Upper gastrointestinal endoscopy or colonoscopy will be included for the study.
  • 2\. If multiple polyps are present, only the largest sessile polyp (but less than or equal to 20 mm diameter) will be considered for the study.

Exclusion Criteria

  • 1\. Age less than 20 years and age greater than 80 years
  • 2\. Pedunculated polyps
  • 3\. Sessile polyps less than 1 mm or greater than 20 mm in diameter
  • 4\. Lesions with ulceration
  • 5\.Friability
  • 6\. Non\- lifting sign or lesions demonstrating deep submucosal invasion
  • 7\. Residual or recurrent lesion
  • 8\. Diagnosed case of inflammatory bowel disease
  • 9\. Coagulopathies
  • 10\. Cardiac pacemaker

Outcomes

Primary Outcomes

Not specified

Similar Trials